vimarsana.com

Latest Breaking News On - Meenakshi dalal - Page 6 : vimarsana.com

Journalists/Professionals: WHO Africa Online Briefing - Veterans Today | Military Foreign Affairs Policy Journal for Clandestine Services

The World Health Organization Africa Media is planning an on-the-record briefing, which is an opportunity for journalists and professionals to ask questions on vaccine rollout and impact of the Omicron variant in Africa.

Nine in 10 African countries set to miss urgent COVID-19 vaccination goal - World

Nine in 10 African countries set to miss urgent COVID-19 vaccination goal Format Nine in 10 African countries set to miss urgent COVID-19 vaccination goal © WHO Brazzaville – As COVID-19 cases in Africa rise for the third week running and vaccines are increasingly scarce, 47 of Africa’s 54 countries nearly 90% are set to miss the September target of vaccinating 10% of their people unless Africa receives 225 million more doses. The new global targets were announced recently at the World Health Assembly, the world’s highest health policy-setting body, and at today’s pace only seven African countries are set to meet them. As Africa nears 5 million COVID-19 cases, numbers are rising week-on-week and increased by nearly 20% to over 88 000 in the week ending on 6 June. The pandemic is trending upwards in 10 African countries, with four nations recording a spike in new cases of over 30% in the past seven days, compared with the previous week. 72% of all new cases were reported

Africa urgently needs 20 million second doses of COVID-19 vaccine - World

Africa urgently needs 20 million second doses of COVID-19 vaccine Format 27 May 2021 Brazzaville, 27 May 2021 – Africa needs at least 20 million doses of the Oxford-AstraZeneca vaccine in the next six weeks to get second doses to all who received a first dose within the 8 12-week interval between doses recommended by the World Health Organization (WHO). A single dose of the Oxford-AstraZeneca vaccine gives around 70% protection for at least 12 weeks. Data on the protection from one dose after 12 weeks is limited, however COVID-19 antibodies have been found in the body up to 6 months after one dose. The full course provided with a 12-week interval gives 81% protection for an extended period.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.